RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Hospira to help biosimilar company Pfenex develop vision treatment

    Hospira to help biosimilar company Pfenex develop vision treatment
    Hospira shares got a big boost last week when Pfizer agreed to buy the company for $15.23 billion. This week, Hospira is paying it forward to a small pharmaceutical company in California, agreeing to help it develop a drug. Pfenex, which issued its...
  • Valeant wins Dendreon with $400M bid

    SEATTLE No rival bidder has topped Valeant Pharmaceuticals International's bid of $400 million for the assets of Dendreon, and an auction scheduled for Thursday has been canceled, the Seattle biotechnology company said Tuesday. Instead, a bankruptcy...
  • Sanofi hires Bayer HealthCare's Brandicourt as new CEO

    French drugmaker Sanofi says it is hiring Bayer HealthCare Chairman and CEO Olivier Brandicourt as its next CEO. Sanofi said Thursday Brandicourt, 59, will start on April 2. He has been Bayer HealthCare's chairman and CEO since November 2013, and was...
  • Pfizer buying Hospira for about $15.23B, will pay $90 per share in cash

    Pfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its established global pharmaceutical business. The buyout will also help Pfizer tap into the growing market for biosimilars, which are cheaper versions of biologic...
  • Pfizer Bets $15 Billion On New Sort of Generics

    c.2015 New York Times News Service Pfizer is making a $15.2 billion bet on the drug industry's new, more elite class of generics: costly, complex copies of already expensive biotech drugs. In its offer on Thursday to buy Hospira for $90 a share, or...
  • Reduce your drug costs instantly with these simple changes

    As health insurers shift more of the cost burden to consumers, the average U.S. worker with employer-provided coverage now pays $9,695 per year in premiums and out-of-pocket costs for a family of four -- a 118 percent increase over the past decade,...
  • Uber, Carnegie Mellon partnering on driverless car research

    Uber, Carnegie Mellon partnering on driverless car research
    PITTSBURGH — Ride-sharing service Uber is partnering with Carnegie Mellon University on a Pittsburgh research lab both hope could lead to the development of driverless cars. Carnegie Mellon and its Robotics Institute have been working on...
  • Medicare would get power to negotiate what it pays for pricey medications

    With patients facing greater exposure to the high cost of new medications, President Barack Obama on Monday called for government to use its buying power to squeeze drug companies for lower prices. Obama's budget asks Congress to authorize Medicare to...
  • Health insurer Aetna's 4th quarter profit drops but matches expectations, 2015 forecast climbs

    Aetna closed 2014 by matching Wall Street earnings expectations, and the insurer raised its forecast for 2015 thanks in part to a price break it got on some expensive hepatitis C treatments. The nation's third-largest health insurer said Tuesday that...
  • Uber, Carnegie Mellon partnering on Pittsburgh research lab, will focus on driverless cars

    Ride-sharing service Uber is partnering with Carnegie Mellon University on a Pittsburgh research lab both hope could lead to the development of driverless cars. Carnegie Mellon and its Robotics Institute have been working on driverless vehicles for...
  • Alexion Pharmaceuticals Names New CEO

    Alexion Pharmaceuticals Names New CEO
    Alexion Pharmaceuticals Inc. in Cheshire has named a new chief executive, David L. Hallal, to replace current CEO and company founder Dr. Leonard Bell, effective April 1. Bell will continue to serve as chairman of the board of directors, the company...